Identifícate
Grupos
Investigadores/as
Resultados
MANUEL EDUARDO
MUÑOZ TORRES
CATEDRÁTICO DE UNIVERSIDAD
Novo Nordisk
Copenhagen, Dinamarca
Estás en
Colaboraciones
Novo Nordisk
Publicaciones en colaboración con investigadores/as de Novo Nordisk (2)
2015
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
Diabetes, Obesity and Metabolism
2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial
The Lancet, Vol. 379, Núm. 9825, pp. 1498-1507
Contactar
Aviso Legal
translate
es
arrow_drop_down
translate
es
arrow_drop_down
ca
eu
gl
en
fr
de